After participating in the Appropriate selection of patients for 1st line monotherapy in advanced or unresectable HCC and treatment management in relation with AEs Meeting on Tuesday, November 23rd 2021, you told us that you intended to change your clinical practice as a result of what you had learnt. Have you made that change?